Tab mannitol?

What is Tab Mannitol used for?

Tab Mannitol is an osmotic diuretic medication used to help reduce elevated intracranial pressure (ICP) and increase cerebral blood flow in patients with acute brain injury or stroke. It is also used to reduce elevated ICP in head trauma patients.

How does Tab Mannitol work?

Tab Mannitol works by drawing water into the bloodstream from brain tissue, reducing the amount of water in the brain and thereby decreasing ICP. This can help reduce pressure on the brain and promote the reabsorption of excess fluids.

What are the potential side effects of Tab Mannitol?

Common side effects of Tab Mannitol include renal impairment, dehydration, electrolyte imbalances, and nausea. Less common side effects can include hypokalemia, hypernatremia, and hyperbilirubinemia [1].

Why is Tab Mannitol used in medical procedures?

Tab Mannitol is often used as an adjunctive therapy in the management of elevated ICP. It is typically used in conjunction with other treatments, such as sedation and mechanical ventilation, to help reduce ICP and promote cerebral blood flow [2].

When should Tab Mannitol not be used?

Tab Mannitol should not be used in patients with severe hypovolemia or significant dehydration, as it can worsen these conditions. It should also be used with caution in patients with pre-existing renal impairment or electrolyte imbalances.

What is the patent status of Tab Mannitol?

Tab Mannitol is a generic medication, and its patent status varies depending on the country and region. According to DrugPatentWatch.com, the patent for mannitol expired in 1994 in the United States [3].

Can biosimilars enter the market before patent expiry?

No, biosimilars cannot enter the market before the patent expiry of the original medication. The Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA) establish rules for the approval and marketing of biosimilars, requiring that they wait until after the original patent has expired before entering the market.

References:

[1] UpToDate. (2022). Mannitol: Overview. Retrieved from https://www.uptodate.com/contents/mannitol-overview

[2] American Association of Neurological Surgeons. (2022). Management of Elevated Intracranial Pressure. Retrieved from https://www.aans.org/Patients/Neurosurgical-Treatment-and-Therapy/Head-Injury/Management-of-Elevated-Intracranial-Pressure

[3] DrugPatentWatch.com. (2022). Mannitol Patent Expiration Date. Retrieved from https://drugpatentwatch.com/patent/Mannitol